NIOSHTIC-2 Publications Search

CYP1A induction and human risk assessment: an evolving tale of in vitro and in vivo studies.

Ma-Q; Lu-AYH

Drug Metab Dispos 2007 Jul; 35(7):1009-1016

http://dx.doi.org/10.1124/dmd.107.015826

20032330

CYP1A1 and 1A2 play critical roles in the metabolic activation of carcinogenic polycyclic aromatic hydrocarbons (PAHs) and heterocyclic aromatic amines/amides (HAAs), respectively, to electrophilic reactive intermediates, leading to toxicity and cancer. CYP1As are highly inducible by PAHs and halogenated aromatic hydrocarbons via aryl hydrocarbon receptor-mediated gene transcription. The impact of CYP1A induction on the carcinogenic and toxic potentials of environmental, occupational, dietary, and therapeutic chemicals has been a central focus of human risk evaluation and has broadly influenced the fields of cancer research, toxicology, pharmacology, and risk assessment over the past half-century. From the early discovery of CYP1A induction and its role in protection against chemical carcinogenesis in intact animals, to the establishment of CYP1A enzymes as the principal cytochromes P450 for bioactivation of PAHs and HAAs in in vitro assays, to the recent realization of an essential protective role of CYP1A in benzo[a]pyrene-induced lethality and carcinogenesis with CYP1A knockout mice, the understanding of the interrelation between CYP1A induction and chemical safety has followed a full circle. This unique path of CYP1A research underscores the importance of whole animal and human studies in chemical safety evaluation.

Analytical-processes; Health-hazards; Health-protection; Health-services; Safety-education; Safety-monitoring; Safety-practices; Cancer-rates; Risk-factors; Risk-analysis; Toxic-effects; Toxic-gases; Toxic-vapors; Toxicopathology; Pharmacology; Bioactivation; Chemical-analysis; Chemical-composition; Chemical-indicators; Chemical-properties; Chemical-synthesis; Hazardous-materials; Animal-studies; Humans; Safety-measures; Safety-research

Qiang Ma, Receptor Biology Laboratory, TMBB/HELD/NIOSH/CDC, Mailstop 3014, 1095 Willowdale Rd., Morgantown, WV 26505

DMDSAI

20070701

Journal Article

qam1@cdc.gov

2007

7

0090-9556

HELD

Drug Metabolism and Disposition

WV; NJ